Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events.

Teiger E, Thambo JB, Defaye P, Hermida JS, Abbey S, Klug D, Juliard JM, Pasquie JL, Rioufol G, Lepillier A, Elbaz M, Horvilleur J, Brenot P, Pierre B, Le Corvoisier P; French National Left Atrial Appendage Closure Registry (FLAAC) Investigators.

Circ Cardiovasc Interv. 2018 Mar;11(3):e005841. doi: 10.1161/CIRCINTERVENTIONS.117.005841.

PMID:
29540492
2.

Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve.

Bleiziffer S, Erlebach M, Simonato M, Pibarot P, Webb J, Capek L, Windecker S, George I, Sinning JM, Horlick E, Napodano M, Holzhey DM, Petursson P, Cerillo A, Bonaros N, Ferrari E, Cohen MG, Baquero G, Jones TL, Kalra A, Reardon MJ, Chhatriwalla A, Gama Ribeiro V, Alnasser S, Van Mieghem NM, Rustenbach CJ, Schofer J, Garcia S, Zeus T, Champagnac D, Bekeredjian R, Kornowski R, Lange R, Dvir D.

Heart. 2018 May;104(10):828-834. doi: 10.1136/heartjnl-2017-312422. Epub 2018 Jan 19.

PMID:
29352008
3.

Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI.

Auffret V, Lefevre T, Van Belle E, Eltchaninoff H, Iung B, Koning R, Motreff P, Leprince P, Verhoye JP, Manigold T, Souteyrand G, Boulmier D, Joly P, Pinaud F, Himbert D, Collet JP, Rioufol G, Ghostine S, Bar O, Dibie A, Champagnac D, Leroux L, Collet F, Teiger E, Darremont O, Folliguet T, Leclercq F, Lhermusier T, Olhmann P, Huret B, Lorgis L, Drogoul L, Bertrand B, Spaulding C, Quilliet L, Cuisset T, Delomez M, Beygui F, Claudel JP, Hepp A, Jegou A, Gommeaux A, Mirode A, Christiaens L, Christophe C, Cassat C, Metz D, Mangin L, Isaaz K, Jacquemin L, Guyon P, Pouillot C, Makowski S, Bataille V, Rodés-Cabau J, Gilard M, Le Breton H; FRANCE TAVI Investigators.

J Am Coll Cardiol. 2017 Jul 4;70(1):42-55. doi: 10.1016/j.jacc.2017.04.053.

PMID:
28662806
4.

6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).

Didier R, Morice MC, Barragan P, Noryani AAL, Noor HA, Majwal T, Hovasse T, Castellant P, Schneeberger M, Maillard L, Bressolette E, Wojcik J, Delarche N, Blanchard D, Jouve B, Ormezzano O, Paganelli F, Levy G, Sainsous J, Carrie D, Furber A, Berlan J, Darremont O, Le Breton H, Lyuycx-Bore A, Gommeaux A, Cassat C, Kermarrec A, Cazaux P, Druelles P, Dauphin R, Armengaud J, Dupouy P, Champagnac D, Ohlmann P, Ben Amer H, Kiss RG, Ungi I, Gilard M.

JACC Cardiovasc Interv. 2017 Jun 26;10(12):1202-1210. doi: 10.1016/j.jcin.2017.03.049.

PMID:
28641840
5.

Interobserver variability in the classification of congenital coronary abnormalities: A substudy of the anomalous connections of the coronary arteries registry.

Koutsoukis A, Halna du Fretay X, Dupouy P, Ou P, Laissy JP, Juliard JM, Hyafil F, Aubry P; ANOCOR Investigators.

Congenit Heart Dis. 2017 Dec;12(6):726-732. doi: 10.1111/chd.12504. Epub 2017 Jun 21.

PMID:
28639359
6.

Rapid pacing using the left ventricular guidewire: Reviving an old technique to simplify BAV and TAVI procedures.

Faurie B, Abdellaoui M, Wautot F, Staat P, Champagnac D, Wintzer-Wehekind J, Vanzetto G, Bertrand B, Monségu J.

Catheter Cardiovasc Interv. 2016 Nov 15;88(6):988-993. doi: 10.1002/ccd.26666. Epub 2016 Aug 11.

PMID:
27510946
7.

Transcatheter Replacement of Failed Bioprosthetic Valves: Large Multicenter Assessment of the Effect of Implantation Depth on Hemodynamics After Aortic Valve-in-Valve.

Simonato M, Webb J, Kornowski R, Vahanian A, Frerker C, Nissen H, Bleiziffer S, Duncan A, Rodés-Cabau J, Attizzani GF, Horlick E, Latib A, Bekeredjian R, Barbanti M, Lefevre T, Cerillo A, Hernández JM, Bruschi G, Spargias K, Iadanza A, Brecker S, Palma JH, Finkelstein A, Abdel-Wahab M, Lemos P, Petronio AS, Champagnac D, Sinning JM, Salizzoni S, Napodano M, Fiorina C, Marzocchi A, Leon M, Dvir D.

Circ Cardiovasc Interv. 2016 Jun;9(6). pii: e003651. doi: 10.1161/CIRCINTERVENTIONS.115.003651.

8.

6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial.

Gilard M, Barragan P, Noryani AAL, Noor HA, Majwal T, Hovasse T, Castellant P, Schneeberger M, Maillard L, Bressolette E, Wojcik J, Delarche N, Blanchard D, Jouve B, Ormezzano O, Paganelli F, Levy G, Sainsous J, Carrie D, Furber A, Berland J, Darremont O, Le Breton H, Lyuycx-Bore A, Gommeaux A, Cassat C, Kermarrec A, Cazaux P, Druelles P, Dauphin R, Armengaud J, Dupouy P, Champagnac D, Ohlmann P, Endresen K, Benamer H, Kiss RG, Ungi I, Boschat J, Morice MC.

J Am Coll Cardiol. 2015 Mar 3;65(8):777-786. doi: 10.1016/j.jacc.2014.11.008. Epub 2014 Nov 16.

9.

ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.

Sinnaeve PR, Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Lambert Y, Danays T, Soulat L, Halvorsen S, Ortiz FR, Vandenberghe K, Regelin A, Bluhmki E, Bogaerts K, Van de Werf F; STREAM investigators.

Circulation. 2014 Sep 30;130(14):1139-45. doi: 10.1161/CIRCULATIONAHA.114.009570. Epub 2014 Aug 26.

10.

Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.

Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Rosell Ortiz F, Ostojic M, Welsh RC, Carvalho AC, Nanas J, Arntz HR, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A, Vandenberghe K, Bogaerts K, Van de Werf F; STREAM Investigative Team.

N Engl J Med. 2013 Apr 11;368(15):1379-87. doi: 10.1056/NEJMoa1301092. Epub 2013 Mar 10.

11.

Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation.

Roy DA, Schaefer U, Guetta V, Hildick-Smith D, Möllmann H, Dumonteil N, Modine T, Bosmans J, Petronio AS, Moat N, Linke A, Moris C, Champagnac D, Parma R, Ochala A, Medvedofsky D, Patterson T, Woitek F, Jahangiri M, Laborde JC, Brecker SJ.

J Am Coll Cardiol. 2013 Apr 16;61(15):1577-84. doi: 10.1016/j.jacc.2013.01.018. Epub 2013 Feb 20.

12.

Usage patterns and 1-year outcomes with the TAXUS Liberté stent: results of the TAXUS OLYMPIA registry.

Ahmed WH, Mendiz OA, Thomas MR; TAXUS OLYMPIA Participating Physicians.

Catheter Cardiovasc Interv. 2011 Jun 1;77(7):979-92. doi: 10.1002/ccd.22805. Epub 2010 Dec 3.

PMID:
20853350
13.

Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study.

El Khoury C, Dubien PY, Mercier C, Belle L, Debaty G, Capel O, Perret T, Savary D, Serre P, Bonnefoy E; AGIR-2 Investigators.

Arch Cardiovasc Dis. 2010 May;103(5):285-92. doi: 10.1016/j.acvd.2010.04.005. Epub 2010 Jun 17.

14.

Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]).

Gilard M, Blanchard D, Helft G, Carrier D, Eltchaninoff H, Belle L, Finet G, Le Breton H, Boschat J; STENTICO Investigators.

Am J Cardiol. 2009 Aug 1;104(3):338-42. doi: 10.1016/j.amjcard.2009.03.053. Epub 2009 Jun 6.

PMID:
19616664
15.

[Diagnostic value of exercise test in the evaluation of sustained ventricular arrhythmia].

Fareh S, Desseigne P, Champagnac D, Chevallier P, Kirkorian G, Touboul P.

Arch Mal Coeur Vaiss. 1994 Jun;87(6):751-6. French.

PMID:
7702418
16.

[Long-term results of implantable automatic defibrillator in 43 patients. Analysis of predictive factors of the first electric shock].

Chevalier P, Kirkorian G, Desseigne P, Atallah G, Champagnac D, Canu G, Claudel JP, Lacet C, Touboul P.

Arch Mal Coeur Vaiss. 1993 Oct;86(10):1459-64. French.

PMID:
8010844
17.

Primary cardiogenic shock during acute myocardial infarction: results of emergency cardiac transplantation.

Champagnac D, Claudel JP, Chevalier P, Desseigne P, Canu G, Chuzel M, Ninet J, Dureau G, Kirkorian G, Lyon L, et al.

Eur Heart J. 1993 Jul;14(7):925-9.

PMID:
8375417
18.

Catheter ablation induced reversal of chronic left ventricular dysfunction in permanent junctional tachycardia.

Saoudi N, Kirkorian G, Atallah G, Desseigne P, Champagnac D, Touboul P.

Pacing Clin Electrophysiol. 1993 May;16(5 Pt 1):954-8.

PMID:
7685893
19.

[Prognosis and long-term development of arrhythmogenic dysplasia of the right ventricle].

Canu G, Atallah G, Claudel JP, Champagnac D, Desseigne D, Chevalier P, de Zuloaga C, Moncada E, Kirkorian G, Touboul P.

Arch Mal Coeur Vaiss. 1993 Jan;86(1):41-8. French.

PMID:
8338399
20.

[Association of cutaneous myxoma, recurrent cardiac myxoma and Cushing's syndrome (Carney's complex). Description of a case and review of the literature].

Champagnac D, Gayet C, Mornex R, Termet H, Pierrard B, Milon H.

Arch Mal Coeur Vaiss. 1990 Jan;83(1):121-4. French.

PMID:
2106300

Supplemental Content

Loading ...
Support Center